Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSenem Duman

About this trial

The aim of this study is to evaluate the effectiveness of patient education delivered through an artificial intelligence (AI)-based mobile application in the management of neurogenic bowel dysfunction in individuals with spinal cord injury. Within the scope of the study, it will be examined whether the mobile application reduces neurogenic bowel scores, contributes to maintaining stool scores within the normal range, and improves the quality of life of individuals. Accordingly, the AI-based education model to be developed is expected to facilitate the integration of bowel management practices into daily life, prevent complications, and enhance social participation.

\-

Eligibility criteria

Qualifiers

Volunteers who consent to participate.

Age over 18 years.

Diagnosed with spinal cord injury (SCI).

Diagnosed with neurogenic bowel dysfunction (NBD).

Disqualifiers

Individuals with mental retardation.

Individuals with visual and/or hearing impairments.

Individuals with communication problems.

Individuals with a history of additional injuries other than SCI (e.g., head trauma, pelvic injury, pelvic surgery).

Trial design

Treatments tested in this trial

  • Mobil Application

Treatment groups

34 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Senem Duman

Lead sponsor

Saglik Bilimleri Universitesi

Sponsor institution